Want to join the conversation?
$MDGN said it has entered into a collaboration with Kyowa Hakko Kirin for the development and commercialization of Kyowa's first-in-class anti-LIGHT monoclonal antibody. The anti-LIGHT monoclonal antibody is a Phase 2-ready biologic with available clinical supply.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.